Latest filing published 11 Aug 2026 for Sotera Health Co, €2.5M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael P. Rutz, listed as chief executive, appears in our data through filings on Sotera Health Co shares, published by SEC (Form 4). Over a trading history stretching from 25 August 2021 to 7 August 2026, the count stands at 13 filings.
No open-market purchase appears, only 3 sales worth €5.7M. Outside the open market, there are 10 share grants. 2026 to date brings no purchases and 1 sale.
The newest entry dates from 11 August 2026: an open-market sale of €2.5M, in Sotera Health Co. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations